GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of PediatricsBusiness Wire • 06/25/25
GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last?Zacks Investment Research • 06/24/25
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual DisabilityBusiness Wire • 06/23/25
GENEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 06/18/25
INVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages Investors with Substantial Losses to Contact the FirmPRNewsWire • 06/13/25
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGSBusiness Wire • 06/12/25
Wall Street Analysts Predict a 32.62% Upside in GENEDX HOLDINGS (WGS): Here's What You Should KnowZacks Investment Research • 05/29/25
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at ScaleBusiness Wire • 05/22/25
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 04/30/25
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?Zacks Investment Research • 04/21/25
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global ScaleBusiness Wire • 04/16/25
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025Business Wire • 04/08/25